Comparison of viscoelastic substances used in phacoemulsification

To evaluate the usefulness of four viscoelastic agents during phacoemulsification: 2% hydroxypropylmethylcellulose (HPMC) (Methocel®), 3% sodium hyaluronate with 4% chondroitin sulfate (Viscoat®), 1 % sodium hyaluronate (Healon®), 1.4% sodium hyaluronate (Healon® GV).

Mixed polymeric systems: New ophthalmic viscosurgical device created by mixin…

The rheological properties of the mixed solution (1:1 and 3:1) showed intermediate characteristics in comparison with the 2 original substances, characterized by a viscosity comparable to that of the superviscous cohesive OVD, but at a higher shear rate (similar to the medium-viscosity dispersive OVD). The new viscous dispersive OVD performed similarly to the mediumviscosity dispersive OVD at l…

Redefining lupus nephritis: clinical implications of pathophysiologic subtypes

Systemic lupus erythematosus (SLE) is associated with a broad spectrum of clinical and immunologic manifestations, of which lupus nephritis is the most common cause of morbidity and mortality. The development of nephritis in patients with SLE involves multiple pathogenic pathways including aberrant apoptosis, autoantibody production, immune complex deposition and complement activation.

Redefining lupus nephritis : Clinical Implication of Patophysiologic Subtypes.

Systemic lupus erythematosus (SLE) is associated with a broad spectrum of clinical and immunologic manifestations, of which lupus nephritis is the most common cause of morbidity and mortality. The development of nephritis in patients with SLE involves multiple pathogenic pathways including aberrant apoptosis, autoantibody production, immune complex deposition and complement activation.

Management of hyperkalaemia in chronic kidney disease

Hyperkalaemia is common in patients with chronic kidney disease (CKD), in part because of the effects of kidney dysfunction on potassium homeostasis and in part because of the cluster of comorbidities (and their associated treatments) that occur in patients with CKD. Owing to its electrophysiological effects, severe hyperkalaemia represents a medical emergency that usually requires prompt inter…

Pathogenesis, diagnosis and management of hyperkalemia

Hyperkalemia is a potentially life-threatening condition in which serum potassium exceeds 5.5 mmol/l. It can be caused by reduced renal excretion, excessive intake or leakage of potassium from the intracellular space. In addition to acute and chronic renal failure, hypoaldosteronism, and massive tissue breakdown as in rhabdomyolysis, are typical conditions leading to hyperkalemia.

Treatment of hyperkalemia: something old, something new

Treatment options for hyperkalemia have not changed much since the introduction of the cation exchange resin, sodium polystyrene sulfonate (Kayexalate, Covis Pharmaceuticals, Cary, NC), over 50 years ago. Although clinicians of that era did not have ready access to hemodialysis or loop diuretics, the other tools that we use today—calcium, insulin, and bicarbonate—were well known to them. C…

Oral Zinc Supplementation for the Treatment of Acute Diarrhea in Children: A …

Evidence supporting the impact of therapeutic zinc supplementation on the duration and severity of diarrhea among children under five is largely derived from studies conducted in South Asia. China experiences a substantial portion of the global burden of diarrhea, but the impact of zinc treatment among children under five has not been well documented by previously published systematic reviews …

Zinc: Role in the management of diarrhea and cholera

Diarrhea and cholera are major health problems. Vibrio cholera , the causative agent of cholera, infects the small intestine, resulting in vomiting, massive watery diarrhea and dehydration. Reduced water and electrolyte absorption is also due to zinc deficiency

Diarrhoea: why children are still and what can be done

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-